PTLA - Portola Pharmaceuticals Q1 2019 Earnings Preview

May, 07 2019 05:30 PM Portola Pharmaceuticals Inc.

Portola Pharmaceuticals (NASDAQ:PTLA) is scheduled to announce Q1 earnings results on Wednesday, May 8th, before market open.
The consensus EPS Estimate is -$1.11 (+13.3% Y/Y) and the consensus Revenue Estimate is $20.6M (+212.1% Y/Y).
Over the last 2 years, ptla has beaten EPS estimates 63% of the time and has beaten revenue estimates 63% of the time.
Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 0 downward.
More news on: Portola Pharmaceuticals, Inc., Earnings news and commentary, , Healthcare stocks news,

Company Name:	Portola Pharmaceuticals Inc.
Stock Symbol:	PTLA
Market:	NASDAQ
Website:	portola.com